E3 PreliminaryModerate confidencePEM ✓GuidelinePeer-reviewedMachine draft
[Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome].
Kuratsune, Hirohiko · Brain and nerve = Shinkei kenkyu no shinpo · 2018 · DOI
Quick Summary
This document presents official diagnostic criteria for ME/CFS developed by Japanese health authorities in 2016. These criteria were designed to help doctors in primary care clinics recognize and diagnose ME/CFS more consistently. The document also summarizes current treatment approaches and expected outcomes based on practices at major medical centers in Japan.
Why It Matters
Standardized diagnostic criteria are essential for ensuring ME/CFS patients receive timely and consistent diagnosis across different healthcare settings. Official clinical guidelines help reduce diagnostic delays and misclassification, enabling patients to access appropriate management sooner. This Japanese guideline contributes to international harmonization of ME/CFS diagnosis and treatment standards.
Observed Findings
- Japanese clinical diagnostic criteria for ME/CFS were formally proposed in 2016 by a Ministry of Health study group.
- The criteria were specifically designed for use by primary care healthcare agencies.
- Major medical institutions in Japan employ various medical treatments for ME/CFS.
Inferred Conclusions
- Standardized diagnostic criteria developed by government health authorities can improve clinical recognition of ME/CFS in primary care.
- Current medical management of ME/CFS in Japan involves multiple treatment approaches employed across major institutions.
Remaining Questions
- Which specific diagnostic criteria elements are most predictive of actual ME/CFS diagnosis in Japanese primary care practice?
- What is the comparative effectiveness of different treatment approaches described in major Japanese institutions?
- How do treatment outcomes and prognosis in the Japanese population compare to other countries?
- What is the long-term prognosis for patients diagnosed using these Japanese criteria?
What This Study Does Not Prove
This guideline does not establish the biological causes or mechanisms of ME/CFS, nor does it present new treatment efficacy data from clinical trials. It does not prove that any particular treatment is curative or definitively effective—it describes current practices rather than validating their evidence base. The guideline represents consensus and institutional experience rather than rigorous experimental evidence.
Tags
Symptom:Post-Exertional MalaiseCognitive DysfunctionUnrefreshing SleepPainFatigue
Metadata
- DOI
- 10.11477/mf.1416200944
- PMID
- 29348370
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026